Results 61 to 70 of about 20,409 (197)

A Comprehensive Disproportionality Analysis of Drug‐Related Head Injury Reports Using the FAERS Database

Brain and Behavior, Volume 16, Issue 6, June 2026.
ABSTRACT Objective This study aimed to identify and characterize drugs associated with reports of head injury through a comprehensive analysis of the FDA Adverse Event Reporting System (FAERS) database. Methods A retrospective disproportionality analysis was conducted on FAERS reports from 2004 to 2023.
Jiaqi Guo, Luming Wei, Junfeng Liu, Jimei Zhang, He Wang, Wanjun Lu   +5 more
wiley   +1 more source

Comparison of Interferon‐Based and Interferon‐Free Treatments on the Prognosis of Hepatocellular Carcinoma After Hepatitis C Virus‐Sustained Virological Response: A Multicenter Study

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Aim We examine the impact of interferon (IFN)‐based and IFN‐free treatment on the prognosis of hepatocellular carcinoma (HCC) after hepatitis C virus (HCV) sustained virological response (SVR). Methods Clinical information was collected on 311 cases of HCC after HCV‐SVR from 16 facilities affiliated with the Kyushu Liver Surgery Study Group ...
Shinji Itoh, Norifumi Iseda, Tomoharu Yoshizumi, Takao Ide, Hirokazu Noshiro, Hisamune Sakai, Toru Hisaka, Masao Nakashima, Hiroaki Nagano, Hirohisa Okabe, Hiromitsu Hayashi, Atsushi Miyoshi, Kenji Kitahara, Yuko Takami, Atsushi Nanashima, Tamotsu Kuroki, Yuichi Endo, Kohji Okamoto, Masatoshi Kajiwara, Masahiko Sakoda, Toru Beppu, Mitsuhisa Takatsuki, Susumu Eguchi   +22 more
wiley   +1 more source

Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C

Journal of Nepal Medical Association, 2011
Until HCV NS3/4A protease inhibitors become available at the end of 2011, the combination pegylated-interferon (PEG-IFN)-alfa and ribavirin (RBV) will remain the standard treatment for chronic hepatitis C patients.
T Kanda, O Yokosuka
doaj   +1 more source

ERDHEIM‐Chester Disease: Two Fatal Cases With Unusual Presentations

Clinical Case Reports, Volume 14, Issue 6, June 2026.
Fluorodeoxyglucose positron emission tomography‐computed tomography (FDG PET‐CT) demonstrated markedly increased metabolic activity in serosal surfaces including pericardium, pleura, and renal fascia, as well as diffuse uptake along vascular walls, particularly the entire aorta.
Ribero‐Vargas Daniel Andres, C. Álvarez Payares José, Murillo‐Pérez Juliana   +2 more
wiley   +1 more source

Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection

Kaohsiung Journal of Medical Sciences, 2017
Posttransplant hepatitis C virus (HCV) recurrence is universal in chronic hepatitis C recipients. Antiviral therapy is suggested after liver transplant to halt disease progression.
Ta-Ya Lin, Ming-Lun Yeh, Ching-I Huang, Yao-Li Chen, Chia-Yen Dai, Jee-Fu Huang, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Ming-Lung Yu, Wan-Long Chuang   +10 more
doaj   +1 more source

PEG-INTERFERON ALPHA-2A AND LOW-DOSE RIBAVIRIN FOR TREATMENT OF HEPATITIS C VIRUS INFECTION IN PATIENTS WITH SICKLE CELL ANEMIA IN SAUDI ARABIA.

Mediterranean Journal of Hematology and Infectious Diseases, 2014
Introduction: Data regarding the safety and efficacy of antiviral therapy with pegylated interferon and ribavirin in patients with sickle cell disease and hepatitis C virus (HCV) infection are scanty.
Adnan Agha
doaj  

Clinical significance blood platelet count in patients with chronic hepatitis C on the background of the various options combined antiviral therapy

Журнал инфектологии, 2014
The purpose of this research is the study of the dynamics of platelet count in blood of patients with chronic hepatitis C on the background of the combined antiviral therapy with standard or pegylated interferon-α in combination with ribavirin.
K. V. Zhdanov, D. A. Gusev, K. V. Kozlov, A. V. Shekurov   +3 more
doaj   +1 more source

Mogamulizumab as Bridge to Thiotepa‐Based Allogeneic Haematopoietic Stem Cell Transplantation in Sézary Syndrome: A Single‐Centre Experience

eJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Introduction Sézary syndrome (SS) is an aggressive cutaneous T‐cell lymphoma for which allogeneic haematopoietic stem cell transplantation (allo‐HSCT) represents the only potentially curative treatment. Methods We report a single‐centre series of three consecutive SS patients treated with mogamulizumab as bridging therapy to allo‐HSCT using ...
Simone Maifredi, Raffaella Sala, Chiara Bottelli, Chiara Pagani, Angela Passi, Rosa Daffini, Alessia Pantaleo, Domenico Russo, Michele Malagola, Marina Venturini, Daniele Avenoso, Alessandra Tucci   +11 more
wiley   +1 more source

Theranostic Advancements in Brain Cancer: Promising Approaches for Emerging Therapy

MedComm – Oncology, Volume 5, Issue 2, June 2026.
Strategies for improving intra‐arterial administration (A) and photodynamic therapy in brain cancer (B). Improving intra‐arterial (IA) administration and photodynamic therapy (PDT) for brain cancer involves enhancing tumor targeting and breaching the blood–brain barrier (BBB). Key strategies include super selective catheterization, using osmotic agents
Bipraban Khanra, Manoj Kumar Sarangi
wiley   +1 more source

De novo Cryoglobulinaemic Mononeuritis Multiplex during Treatment of Chronic Hepatitis C Infection: A Viral Effect or Induced by Pegylated Interferon Alpha

Case Reports in Gastroenterology, 2012
Cryoglobulinaemic mononeuritis multiplex (MNM) is an extrahepatic manifestation of chronic hepatitis C virus (HCV) infection for which interferon-based antiviral therapy is currently the treatment of choice.
J.R. Potts, S. Atkinson, J.A. Aram, J. Tibble, K.A. Davies, S. Verma   +5 more
doaj   +1 more source